Tiapride has been found to cause excess prolactin levels in plasma,[REF] which can cause decreased libido, infertility and increased risk of breast cancer [REF].
The side-effect reported most commonly to the U.S. Food and Drug Administration (FDA) is rhabdomyolysis, a condition characterized by muscle tissue breakdown [REF].